Figure 2From: CBFB-MYH11 hypomethylation signature and PBX3 differential methylation revealed by targeted bisulfite sequencing in patients with acute myeloid leukemiaHypomethylation signature in inv(16) AML. Hypomethylation of MN1 (A), SPARC (B), ST18 (C) and DHRS3 (D) regulatory regions in inv(16) patients compared to AML M4 without inv(16), other AML subtypes and healthy controls; asterisks correspond to statistically significant changes of expression in inv(16) patients versus other groups, ***P < 0.0001.Back to article page